BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32574697)

  • 21. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
    [No Abstract]   [Full Text] [Related]  

  • 22. China is tightening its grip on coronavirus research.
    Silver A; Cyranoski D
    Nature; 2020 Apr; 580(7804):439-440. PubMed ID: 32296161
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
    Marmor MF
    Am J Ophthalmol; 2020 Aug; 216():A1-A2. PubMed ID: 32439074
    [No Abstract]   [Full Text] [Related]  

  • 24. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
    Abu-Raya B; Gantt S; Sadarangani M
    CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
    [No Abstract]   [Full Text] [Related]  

  • 25. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 26. Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
    Coudeville L; Gomez GB; Jollivet O; Harris RC; Thommes E; Druelles S; Chit A; Chaves SS; Mahé C
    Vaccine; 2020 Nov; 38(48):7588-7595. PubMed ID: 33097312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbicidal actives with virucidal efficacy against SARS-CoV-2.
    Ijaz MK; Whitehead K; Srinivasan V; McKinney J; Rubino JR; Ripley M; Jones C; Nims RW; Charlesworth B
    Am J Infect Control; 2020 Aug; 48(8):972-973. PubMed ID: 32461067
    [No Abstract]   [Full Text] [Related]  

  • 29. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Regulation of COVID-19 "Challenge" Studies.
    Menikoff J
    Am J Bioeth; 2020 Jul; 20(7):80-82. PubMed ID: 32716768
    [No Abstract]   [Full Text] [Related]  

  • 31. All together to Fight COVID-19.
    Momtazmanesh S; Ochs HD; Uddin LQ; Perc M; Routes JM; Vieira DN; Al-Herz W; Baris S; Prando C; Rosivall L; Abdul Latiff AH; Ulrichs T; Roudenok V; Aldave Becerra JC; Salunke DB; Goudouris E; Condino-Neto A; Stashchak A; Kryvenko O; Stashchak M; Bondarenko A; Rezaei N
    Am J Trop Med Hyg; 2020 Jun; 102(6):1181-1183. PubMed ID: 32323644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Urgent Need for "Common Cold Units" to Study COVID-19.
    Halstead SB
    Am J Trop Med Hyg; 2020 Jun; 102(6):1152-1153. PubMed ID: 32274988
    [No Abstract]   [Full Text] [Related]  

  • 33. COVID-19: the virus in the control of culture?
    Ferreira LL; Chagas ACP; Bernardo WM
    Rev Assoc Med Bras (1992); 2020 Mar; 66(3):242-244. PubMed ID: 32520136
    [No Abstract]   [Full Text] [Related]  

  • 34. Lithium for the 2019 novel coronavirus.
    Gómez-Bernal G
    Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
    [No Abstract]   [Full Text] [Related]  

  • 35. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19: A time for renewed recognition of science.
    EBioMedicine; 2020 Jun; 56():102869. PubMed ID: 32580894
    [No Abstract]   [Full Text] [Related]  

  • 37. Retraction of Studies on Potential Drug Therapies for COVID-19: A Call for Reliability and Scientific Integrity.
    Guzman-Prado Y
    Am J Cardiol; 2020 Oct; 132():173. PubMed ID: 32713654
    [No Abstract]   [Full Text] [Related]  

  • 38. Riding the coronacoaster of uncertainty.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202
    [No Abstract]   [Full Text] [Related]  

  • 39. The Wuhan SARS-CoV-2-What's next for China.
    Lu H; Stratton CW; Tang YW
    J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible treatment of Covid-19 with a therapeutic vaccine.
    Myint A; Jones T
    Vet Rec; 2020 Apr; 186(13):419. PubMed ID: 32245869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.